Predictors of Renal Failure in Patients Treated with the Total Artificial Heart

Implantable mechanical circulatory support (MCS) devices are used in patients with progressive heart failure either as destination therapy or a bridge-to-transplant. Left ventricular assist devices (LVAD) have become commonplace with development of continuous flow platforms. LVADs are effective in selected patients and improve quality of life and reduce mortality.1 However, patients with severe biventricular dysfunction or anatomical contraindications such as small or non-dilated ventricles (i.e.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Source Type: research